House Passes Alexander Compounding Agreement

Sunday, September 29, 2013

The  House of Representatives has passed a legislative agreement Senator Lamar Alexanderreached with House and Senate health committee leaders to clarify oversight of the nation’s compounding facilities.

 

Senator Alexander said: “This is a big step toward preventing another nightmare for Tennesseans like last year’s tragic meningitis outbreak, which the FDA commissioner tells us will happen again if we don’t fix the uncertainty over who’s in charge of compounding facilities. The House has passed our agreement to make it clear exactly who is in charge of overseeing each compounding facility, so there will be no questions about who’s on the flagpole. I urge the Senate to act swiftly and send this bill to the president to sign.”

 

Today’s bill represented an agreement by Alexander and Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Tom Harkin (D-Iowa), House Energy and Commerce Chairman Fred Upton (R-Mich.) and Ranking Member Henry Waxman (D-Calif.). The bill clarifies current federal law regarding pharmacy compounding and resolves the patchwork of current federal regulation by applying a uniform standard nationwide.

 

Last November, when the Senate HELP Committee held its first hearing on the deadly meningitis outbreak, Alexander called for a new model of oversight of sterile compounding pharmacies.

One year ago, the meningitis outbreak caused by contaminated compounded drugs from the New England Compounding Center alerted the nation that providers and patients need sources of safe compounded drugs.  Following the outbreak, a bipartisan group of HELP Committee Senators— led by Chairman Harkin, Ranking Member Alexander, Sen. Pat Roberts (R-Kan.), and Sen. Al Franken (D-Minn.)—developed legislation to help ensure that quality compounded drugs are available to patients who need them.

Among other highlights, the legislation:

  • Distinguishes compounders engaged in traditional pharmacy practice from those making large volumes of compounded drugs without individual prescriptions. Compounders who wish to practice outside the scope of traditional pharmacy practice can register as outsourcing facilities, but those who choose to remain traditional pharmacies will continue to be primarily regulated by State Boards of Pharmacy as they are in current law.
  • Defines the Food and Drug Administration’s (FDA’s) role in oversight of outsourcing facilities.  Outsourcing facilities would be subject to FDA oversight in much the same way as traditional manufacturers.  FDA will know who these outsourcers are and what they are making, receive adverse event reports about compounded drugs, and have the authority and resources to conduct risk-based inspections.  The legislation will give providers and patients the option of purchasing products from outsourcing facilities that comply with FDA quality standards.
  • Offers providers and patients better information about compounded drugs.  The legislation directs FDA to make a list of FDA-regulated outsourcing facilities available on FDA’s website, requires detailed labeling on compounded drugs, and prohibits false and misleading advertising.
  • Clarifies current federal law regarding pharmacy compounding.  The legislation strikes unconstitutional provisions in current law, resolving the patchwork of current federal regulation and applying a uniform standard nationwide.

 

The bill is supported by the Tennessee Pharmacists Association, who stated: "We believe this compromise proposal offers an effective approach to address complex issues surrounding compounded medications by having the Food and Drug Administration (FDA) focus on entities that are compounding outside the scope of traditional pharmacy compounding while leaving traditional pharmacy compounding under the oversight of state boards of pharmacy."

The bill also includes legislation based upon a bill passed unanimously by the Senate health committee that improves patient safety by replacing today’s patchwork of state pharmaceutical drug tracing laws with a strong, uniform standard that would ultimately result in electronic, interoperable unit level drug tracing for the entire country.  The last comprehensive effort to establish safeguards for the drug distribution supply chain was twenty-five years ago.  This bipartisan, bicameral draft is the result of several years of work to address the growing problem of pharmaceutical theft, counterfeiting, and diversion.  

Among other highlights, the legislation:

  • Develops a workable pathway to unit-level tracing in a decade. Over the course of seven years, the major sectors of the pharmaceutical supply chain, such as manufacturers, repackagers, wholesale distributors, and dispensers will all be passing and holding onto key information about each drug’s distribution history.  Within ten years, supply chain stakeholders will participate in electronic, interoperable drug tracing.
  • Strengthens licensure requirements for wholesale distributors and third-party logistics providers.  Wholesale distributors will have higher standards for their licenses nationwide, and third-party logistics providers will be recognized for the first time as a part of the drug supply chain. FDA will also keep a database of wholesalers that will be available to the public through the FDA’s website, allowing consumers and members of the drug supply chain to identify appropriately licensed wholesalers.
  • Establishes nationwide drug serial numbers.  Four years after the date of enactment, manufacturers will serialize drugs in a consistent way across the industry.  This will allow for efficient tracing to respond to recalls and notices of theft and counterfeiting.   

BRA-VO! A Fashion Show Celebrating Life After Breast Cancer Will Be April 19

Breast Cancer Support Services, Inc., a Chattanooga based nonprofit, is hosting the third annual BRA-VO! Fashion Show. All of the models are area breast cancer survivors showcasing some of the hottest new fashions from some of Chattanooga’s best boutiques. This unique fashion show is open to the public and will take place at Track 29 on Sunday, April 19 . Doors will open at ... (click for more)

Healthcare Services Credit Union Honors Founder With Donation To Alzheimer's Association

Members of Healthcare Services Credit Union presented the Alzheimer’s Association with a $1,000 donation in memory of their late founder, Walker Haddock.  Mr. Haddock founded Erlanger Hospital Credit Union in 1952 with nine other volunteers from employees’ requests for financial services. At the time he worked in payroll and human resources for Erlanger. This establishment ... (click for more)

Chattanooga Police Detective Karl Fields Terminated On Code Of Conduct Charges

Karl Fields, former Chattanooga Police detective, was terminated on Wednesday on code of conduct charges. The Chattanooga Police Department said it received a correspondence from the Hamilton County District Attorney’s Office o n Sept. 4, 2014,  informing it of allegations of inappropriate behavior committed by a CPD investigator during the course of a rape investigation. ... (click for more)

Autopsy Says 5-Year-Old Whitwell Boy Died Of Blunt Force Trauma

An autopsy on five-year-old Lucas Dillon of Whitwell says he died of blunt force trauma. The TBI is investigating the death, which is being treated as a homicide. The child, who lived on Jewell Lane Road, was injured on Saturday and died in a hospital on Monday. Lucas was a student at Whitwell Head Start. (click for more)

Physicians Thank Their Patients On Doctor’s Day

March 30 has been set aside as National Doctors’ Day since 1933 as a time to recognize the contributions made by our physicians. While the recognition is appreciated, our greatest satisfaction comes from caring for our patients.  For 132 years, the Chattanooga-Hamilton County Medical Society has been the physicians’ voice as we worked together to improve health of our community. ... (click for more)

Roy Exum: A Tragedy And A Triumph

Two summers ago there was a 15-year-old boy at Atlanta’s Egleston children’s hospital with two big problems. Doctors had discovered the child had dilated cardiomyopathy and the left ventricle in his heart was failing to pump enough blood. Doctors predicted that without a heart transplant he would only live six to nine more months. His other problem was a court-ordered monitoring ... (click for more)